neostem inc (NBS:NASDAQ CM)
Robin L. Smith M.D., MBA,Ro
Executive Chairman and Chief Executive Officer, Neostem, Inc.
|Age||Total Calculated Compensation||This person is connected to 70 board members in 8 different organizations across 9 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Robin L. Smith, M.D., MBA, Ro, has been Executive Chairman and Chief Executive Officer of Neostem, Inc. at Amorcyte, LLC and Progenitor Cell Therapy, LLC since June 2, 2006. Dr. Smith served as Chief Operating Officer - Ip2m Division and Senior Vice President - Ip2m Division at Dialog Group, Inc. Dr. Smith serves as Member of Advisory Board at Wellfleet Partners Investment Arm. They serves as Member of Medical Advisory Board at House of Brussels Chocolates Inc. They ...
420 Lexington AvenuePhone: 212-584-4180
New York, New York 10170
Board Members Memberships*
Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Governance Committee
Executive Chairman and Chief Executive Officer
University of Pennsylvania - The Wharton School
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Michael D. West Ph.D.||Chief Executive Officer, President and Director|
|Matthew T. Plavan||Chief Executive Officer and Director|
Cesca Therapeutics Inc.
|Paul K. Wotton Ph.D.||Chief Executive Officer, President, Director and Member of Pricing Committee|
Advanced Cell Technology Inc.
|Zami Aberman||Executive Chairman and Chief Executive Officer|
Pluristem Therapeutics, Inc.
|$503.7K||Compensation as of Fiscal Year 2013.|